Results 61 to 70 of about 2,106,514 (153)

Hetero[3.1.1]propellanes. [PDF]

Nat Chem
Revie RI, Dasgupta A, Biddick Y, Christensen KE, Smith RC, Anderson EA.   +5 more
europepmc   +1 more source

Pseudo-Richter transformation in a patient with chronic lymphocytic leukemia after cessation of fixed duration venetoclax/ibrutinib treatment. [PDF]

Ann Hematol
Battegay R, Heim D, Dirnhofer S.
europepmc   +1 more source

Comment on AlAsmari et al. Venetoclax Induces Cardiotoxicity through Modulation of Oxidative-Stress-Mediated Cardiac Inflammation and Apoptosis via NF-κB and BCL-2 Pathway. <i>Int. J. Mol. Sci.</i> 2022, <i>23</i>, 6260. [PDF]

Int J Mol Sci
Trela BA, Guffroy MR.
europepmc   +1 more source

Where next for BTKi-BCL2i combinations in mantle cell lymphoma? [PDF]

Br J Haematol
Eyre TA.
europepmc   +1 more source

Accessing Medium-Sized Bridged Heterocycles via EnT-Catalyzed Intermolecular Dearomative (5 + 4) Cycloaddition of Furans and Oxazoles. [PDF]

J Am Chem Soc
Hümpel C, Rana D, Korgitzsch S, Fischer K, Daniliuc CG, Glorius F.   +5 more
europepmc   +1 more source

Synthesis of aryl-fused bicyclo[3.1.1]heptanes and validation as naphthyl bioisosteres. [PDF]

Nat Chem
Kerckhoffs A, Tregear M, Hernández-Lladó P, Runfola M, Shearsmith H, Frank N, Panosetti M, Squire SE, Moir L, Christensen KE, Duarte F, Davies KE, Russell AJ.   +12 more
europepmc   +1 more source

Bridged scaffold editing of carbocycles and heterocycles. [PDF]

Nat Commun
Li J, Yang Y, Dai Z, Chen S, Xiong S, Li G, Zeng L, Cui S.   +7 more
europepmc   +1 more source

Patient-tailored azacitidine, venetoclax and gilteritinib triplet therapy appear to improve tolerability while preserving encouraging clinical outcomes in FLT3-mutated relapsed/refractory AML. [PDF]

Ann Hematol
Arvidsson Kvissberg M, Nilsson C, Landberg N, Österroos A, Papageorgiou A, Uggla B, Lazarevic V, Deneberg S, Jädersten M.   +8 more
europepmc   +1 more source

Photochemical Hetero-cycloadditions. [PDF]

Chem Rev
Rosso C, Corti V, Goti G, Cuadros S, Marcantonio E, Dell'Amico L.   +5 more
europepmc   +1 more source

Recent developments in the organocatalytic asymmetric cycloaddition/annulation reactions involving indolylmethanols. [PDF]

RSC Adv
Patel A, Harshit, Iype E, Kumar I.
europepmc   +1 more source